Plasma biomarkers of brain injury, such as brain‐derived neurotrophic factor (BDNF), glial‐fibrillary‐acidic protein(GFAP), and astrocytic‐protein‐S100B may be used for diagnosis and monitoring of foals with NMS. The gene discussed is GFAP; the disease is neuroleptic malignant syndrome.